Atlas Trials

Study of Cysteine Hydrochloride for Erythropoietic Protoporphyria

Clinical trial NCT00004831 · COMPLETED

Trial details

NCT number
NCT00004831
Sponsor
FDA Office of Orphan Products Development
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Erythropoietic Protoporphyria
Start date
1996-10-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.